-
biote (BTMD) Appoints Rich Barrera to its Board
-
Truist Lays Out Prelim Thoughts on Impact to Generic Drugs Amid WH Update on Drug Pricing
-
biote Corp. (BTMD) Tops Q1 EPS by 23c ; Offers Guidance
-
biote (BTMD) announces CEO and Board buy 26,000 shares
-
biote Corp. (BTMD) PT Lowered to $6.80 at Jefferies
-
biote Corp. (BTMD) PT Lowered to $7 at Truist Following a 'Challenging' Quarter
-
biote Corp. (BTMD) Misses Q4 EPS by 1c ; Offers Guidance
-
biote (BTMD) Announces CEO Retirement
-
biote Corp. (BTMD) PT Raised to $8 at TD Cowen
-
biote Corp. (BTMD) Tops Q3 EPS by 21c
-
TD Cowen Reiterates Buy Rating on biote Corp. (BTMD)
-
biote Corp. (BTMD) Misses Q2 EPS by 27c ; Offers Guidance
-
biote Corp. (BTMD) PT Raised to $12 at Roth/MKM
-
Truist Securities Reiterates Buy Rating on biote Corp. (BTMD)
-
biote (BTMD) Announces $60M Agreement to Repurchase 8.3M Shares, Cancel 4M Earnout Shares

